Share
17,611 Posts.
lightbulb Created with Sketch. 2548
clock Created with Sketch. 02/06/22
10:58
Share
Originally posted by chucke
↑
Just about everyone thinks it's cool except Mr Market unfortunately LED......the 'hoopla' of trial data and any other positive news appears to 'fall on deaf ears' now.......the downturn mojo is no longer about potential....it's about $$$$$$ in the kitty and longevity.......track record etc etc. The entire biotech sector has copped it in the neck......only an EUA or partnership will turn this ship around. The timing of 2020's CRL has been exquisitely timed for the 'go take a long walk on a short pier' tactic from the FDA......due to the pandemic & other factors......it has now become an extra long walk......LTH will now have to put these in the very dark recesses of the bottom drawer. On the flipside, it's great that the process has been done methodically & carefully this time round.......but more time & patience is required now. I'm still positive about the end game here......just not overly jubilant about the extended delays that yesterday's news indicated was ahead. But hey......we've waited this long....what's a few more months......years...whatever !?
Expand
At $20,000 per quarter a few more months is insolvency.
Last edited by
whytee :
02/06/22
(20min delay)